HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combination Methionine-methylation-axis Blockade: A Novel Approach to Target the Methionine Addiction of Cancer.

AbstractBACKGROUND/AIM:
Cancers are selectively sensitive to methionine (MET) restriction (MR) due to their addiction to MET which is overused for elevated methylation reactions. MET addiction of cancer was discovered by us 45 years ago. MR of cancer results in depletion of S-adenosylmethionine (SAM) for transmethylation reactions, resulting in selective cancer-growth arrest in the late S/G2-phase of the cell cycle. The aim of the present study was to determine if blockade of the MET-methylation axis is a highly-effective strategy for cancer chemotherapy.
MATERIALS AND METHODS:
In the present study, we demonstrated the efficacy of MET-methylation-axis blockade using MR by oral-recombinant methioninase (o-rMETase) combined with decitabine (DAC), an inhibitor of DNA methylation, and an inhibitor of SAM synthesis, cycloleucine (CL). We determined a proof-of-concept of the efficacy of the MET-methylation-axis blockade on a recalcitrant undifferentiated/unclassified soft-tissue sarcoma (USTS) patient-derived orthotopic xenograft (PDOX) mouse model.
RESULTS:
The o-rMETase-CL-DAC combination regressed the USTS PDOX with extensive cancer necrosis.
CONCLUSION:
The new concept of combination MET-methylation-axis blockade is effective and can now be tested on many types of recalcitrant cancer.
AuthorsTakashi Higuchi, Qinghong Han, Norihiko Sugisawa, Jun Yamamoto, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Michael Bouvet, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M Hoffman
JournalCancer genomics & proteomics (Cancer Genomics Proteomics) 2021 Mar-Apr Vol. 18 Issue 2 Pg. 113-120 ISSN: 1790-6245 [Electronic] Greece
PMID33608308 (Publication Type: Journal Article, Review)
CopyrightCopyright© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Chemical References
  • Methionine
Topics
  • Animals
  • Disease Models, Animal
  • Humans
  • Methionine (antagonists & inhibitors)
  • Methylation
  • Mice
  • Mice, Nude
  • Neoplasms (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: